| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Age-related differences in presentation and course of inflammatory bowel disease: an update on the population-based literature
|
Duricova, Dana
|
|
2014
|
|
11 |
p. 1351-1361
11 p.
|
artikel
|
| 2 |
Antibodies against glycoprotein 2 are novel markers of intestinal inflammation in patients with an ileal pouch
|
Werner, Lael
|
|
2013
|
|
11 |
p. e522-e532
nvt p.
|
artikel
|
| 3 |
Anti-GP2 antibodies in inflammatory bowel disease patients with ileal pouch
|
Pavlidis, Polychronis
|
|
2013
|
|
11 |
p. e602-e603
nvt p.
|
artikel
|
| 4 |
Anxiety is associated with impaired tolerance of colonoscopy preparation in inflammatory bowel disease and controls
|
Bessissow, Talat
|
|
2013
|
|
11 |
p. e580-e587
nvt p.
|
artikel
|
| 5 |
A randomized clinical trial of mesalazine suppository: The usefulness and problems of central review of evaluations of colonic mucosal findings
|
Kobayashi, Kiyonori
|
|
2014
|
|
11 |
p. 1444-1453
10 p.
|
artikel
|
| 6 |
Ciprofloxacin and probiotic Escherichia coli Nissle add-on treatment in active ulcerative colitis: A double-blind randomized placebo controlled clinical trial
|
Petersen, Andreas Munk
|
|
2014
|
|
11 |
p. 1498-1505
8 p.
|
artikel
|
| 7 |
Clinical trials in luminal Crohn's disease: A historical perspective
|
Hindryckx, Pieter
|
|
2014
|
|
11 |
p. 1339-1350
12 p.
|
artikel
|
| 8 |
Colesevelam for the treatment of bile acid malabsorption-associated diarrhea in patients with Crohn's disease: A randomized, double-blind, placebo-controlled study
|
Beigel, Florian
|
|
2014
|
|
11 |
p. 1471-1479
9 p.
|
artikel
|
| 9 |
Combination of oral antibiotics may be effective in severe pediatric ulcerative colitis: A preliminary report
|
Turner, Dan
|
|
2014
|
|
11 |
p. 1464-1470
7 p.
|
artikel
|
| 10 |
Contrast-enhanced ultrasonography for assessment of activity of Crohn's disease: The future?
|
Magalhães, Joana
|
|
2013
|
|
11 |
p. e607-
1 p.
|
artikel
|
| 11 |
Crohn's disease outpatients treated with adalimumab have an earlier secondary loss of response and requirement for dose escalation compared to infliximab: A real life cohort study
|
Ma, Christopher
|
|
2014
|
|
11 |
p. 1454-1463
10 p.
|
artikel
|
| 12 |
Development and psychometric testing of inflammatory bowel disease fatigue (IBD-F) patient self-assessment scale
|
Czuber-Dochan, Wladyslawa
|
|
2014
|
|
11 |
p. 1398-1406
9 p.
|
artikel
|
| 13 |
Endoscopic biopsy samples of naïve “colitides” patients: Role of basal plasmacytosis
|
Villanacci, Vincenzo
|
|
2014
|
|
11 |
p. 1438-1443
6 p.
|
artikel
|
| 14 |
Expression of T-cell KV1.3 potassium channel correlates with pro-inflammatory cytokines and disease activity in ulcerative colitis
|
Koch Hansen, Lars
|
|
2014
|
|
11 |
p. 1378-1391
14 p.
|
artikel
|
| 15 |
Faecalibacterium prausnitzii upregulates regulatory T cells and anti-inflammatory cytokines in treating TNBS-induced colitis
|
Qiu, Xinyun
|
|
2013
|
|
11 |
p. e558-e568
nvt p.
|
artikel
|
| 16 |
Family history of inflammatory bowel disease among patients with ulcerative colitis: A systematic review and meta-analysis
|
Childers, Ryan E.
|
|
2014
|
|
11 |
p. 1480-1497
18 p.
|
artikel
|
| 17 |
Health care for osteoporosis in inflammatory bowel disease: Unmet needs in care of male patients?
|
Walldorf, Jens
|
|
2013
|
|
11 |
p. 901-907
7 p.
|
artikel
|
| 18 |
How early to take arms against a sea of troubles? The case for aggressive early therapy in Crohn's disease to prevent fibrotic intestinal strictures
|
Govani, Shail M.
|
|
2013
|
|
11 |
p. 923-927
5 p.
|
artikel
|
| 19 |
Impact of surveillance of hepatitis b and hepatitis c in patients with inflammatory bowel disease under anti-TNF therapies: Multicenter prospective observational study (REPENTINA 3)
|
Loras, C.
|
|
2014
|
|
11 |
p. 1529-1538
10 p.
|
artikel
|
| 20 |
Incidence and initial disease course of inflammatory bowel diseases in 2011 in Europe and Australia: Results of the 2011 ECCO-EpiCom inception cohort
|
Vegh, Z.
|
|
2014
|
|
11 |
p. 1506-1515
10 p.
|
artikel
|
| 21 |
Infliximab is safe and induces sustained remission with complete mucosal healing in Crohn's disease in a patient with pan resistant pseudomonas cystic fibrosis: A case report
|
Gibson, D.J.
|
|
2014
|
|
11 |
p. 1561-1562
2 p.
|
artikel
|
| 22 |
Interleukin-6 is associated with steroid resistance and reflects disease activity in severe pediatric ulcerative colitis
|
Wine, Eytan
|
|
2013
|
|
11 |
p. 916-922
7 p.
|
artikel
|
| 23 |
International variation in medication prescription rates among elderly patients with inflammatory bowel disease
|
Benchimol, Eric I.
|
|
2013
|
|
11 |
p. 878-889
12 p.
|
artikel
|
| 24 |
Intravenous corticosteroids in moderately active ulcerative colitis refractory to oral corticosteroids
|
Llaó, Jordina
|
|
2014
|
|
11 |
p. 1523-1528
6 p.
|
artikel
|
| 25 |
In vitro sensitivity assays and clinical response to glucocorticoids in patients with inflammatory bowel disease
|
Maranville, Joseph C.
|
|
2014
|
|
11 |
p. 1539-1547
9 p.
|
artikel
|
| 26 |
Issue Contents List
|
|
|
2013
|
|
11 |
p. v-vii
nvt p.
|
artikel
|
| 27 |
Issue Contents list
|
|
|
2014
|
|
11 |
p. v-vii
nvt p.
|
artikel
|
| 28 |
Long-term safety and efficacy of adalimumab in Japanese patients with moderate to severe Crohn's disease
|
Watanabe, Mamoru
|
|
2014
|
|
11 |
p. 1407-1416
10 p.
|
artikel
|
| 29 |
May you never forget what is worth remembering: The relation between recall of medical information and medication adherence in patients with inflammatory bowel disease
|
Linn, Annemiek J.
|
|
2013
|
|
11 |
p. e543-e550
nvt p.
|
artikel
|
| 30 |
Mucosal healing in Crohn's disease — Are we reaching as far as possible with capsule endoscopy?
|
Carvalho, Pedro Boal
|
|
2014
|
|
11 |
p. 1566-1567
2 p.
|
artikel
|
| 31 |
Novel de novo mutations of the interleukin-10 receptor gene lead to infantile onset inflammatory bowel disease
|
Lee, Cheng Hiang
|
|
2014
|
|
11 |
p. 1551-1556
6 p.
|
artikel
|
| 32 |
One size fits all? Choosing the right format to convey statistical information
|
Selinger, Christian P.
|
|
2014
|
|
11 |
p. 1565-
1 p.
|
artikel
|
| 33 |
On the physician-completed and the patient-completed Simple Clinical Colitis Activity Index (SCCAI)
|
Walmsley, Russell S.
|
|
2013
|
|
11 |
p. 930-931
2 p.
|
artikel
|
| 34 |
Oral tacrolimus as maintenance therapy for refractory ulcerative colitis—an analysis of outcomes in two London tertiary centres
|
Landy, Jonathan
|
|
2013
|
|
11 |
p. e516-e521
nvt p.
|
artikel
|
| 35 |
Oral treatment with a novel small molecule alpha 4 integrin antagonist, AJM300, prevents the development of experimental colitis in mice
|
Sugiura, Toshihiko
|
|
2013
|
|
11 |
p. e533-e542
nvt p.
|
artikel
|
| 36 |
Portal vein thrombosis after colectomy for ulcerative colitis: Two case reports and proposed novel pathophysiology for this association
|
Mogrovejo, Estela E.
|
|
2013
|
|
11 |
p. 933-934
2 p.
|
artikel
|
| 37 |
Preoperative use of anti-TNF therapy and postoperative complications in inflammatory bowel diseases: A meta-analysis
|
Billioud, Vincent
|
|
2013
|
|
11 |
p. 853-867
15 p.
|
artikel
|
| 38 |
Presenting features and disease course of pediatric ulcerative colitis
|
Aloi, Marina
|
|
2013
|
|
11 |
p. e509-e515
nvt p.
|
artikel
|
| 39 |
Profile of pediatric Crohn's disease in Belgium
|
De Greef, E.
|
|
2013
|
|
11 |
p. e588-e598
nvt p.
|
artikel
|
| 40 |
Relationship between levels of angiogenic and lymphangiogenic factors and the endoscopic, histological and clinical activity, and acute-phase reactants in patients with inflammatory bowel disease
|
Algaba, Alicia
|
|
2013
|
|
11 |
p. e569-e579
nvt p.
|
artikel
|
| 41 |
Reply to Dr. Pavlidis et al's letter
|
Werner, Lael
|
|
2013
|
|
11 |
p. e604-e605
nvt p.
|
artikel
|
| 42 |
Reply to Drs. Walmsley and Casey letter
|
Bennebroek Evertsz', Floor
|
|
2013
|
|
11 |
p. 932-
1 p.
|
artikel
|
| 43 |
Reply to letter on published paper: Improving quality of care in inflammatory bowel disease: What changes can be made today?
|
Panes, Julian
|
|
2014
|
|
11 |
p. 1568-
1 p.
|
artikel
|
| 44 |
Response to a letter commenting on “Vitamin D deficiency in Crohn's disease and healthy controls: A prospective case–control study in The Netherlands”
|
de Bruyn, Jessica R.
|
|
2014
|
|
11 |
p. 1559-1560
2 p.
|
artikel
|
| 45 |
Rising post-colectomy complications in children with ulcerative colitis despite stable colectomy rates in United States
|
Soon, Ing Shian
|
|
2014
|
|
11 |
p. 1417-1426
10 p.
|
artikel
|
| 46 |
Sarcoidosis during therapy with adalimumab in a Crohn's disease patient: A paradoxical effect
|
Kotze, Paulo Gustavo
|
|
2013
|
|
11 |
p. e599-e600
nvt p.
|
artikel
|
| 47 |
Serum hepcidin concentrations correlate with ferritin in patients with inflammatory bowel disease
|
Mecklenburg, Ingo
|
|
2014
|
|
11 |
p. 1392-1397
6 p.
|
artikel
|
| 48 |
Should we treat asymptomatic patients with mildly ulcerated terminal ileum?
|
Marques dos Santos, Carlos Hernique
|
|
2013
|
|
11 |
p. e601-
1 p.
|
artikel
|
| 49 |
Sick leave and disability pension in inflammatory bowel disease: A systematic review
|
Büsch, Katharina
|
|
2014
|
|
11 |
p. 1362-1377
16 p.
|
artikel
|
| 50 |
Subcutaneous ustekinumab for the treatment of anti-TNF resistant Crohn's disease—The McGill experience
|
Kopylov, U.
|
|
2014
|
|
11 |
p. 1516-1522
7 p.
|
artikel
|
| 51 |
Superficial abdominal thrombophlebitis (Mondor's disease) presenting as loss of response to adalimumab in a Crohn's disease patient
|
Ben-Horin, Shomron
|
|
2014
|
|
11 |
p. 1557-1558
2 p.
|
artikel
|
| 52 |
The effectiveness and safety of rescue treatments in 108 patients with steroid-refractory ulcerative colitis with sequential rescue therapies in a subgroup of patients
|
Protic, Marijana
|
|
2014
|
|
11 |
p. 1427-1437
11 p.
|
artikel
|
| 53 |
The IMPACT-III (HR) Questionnaire: A valid measure of health-related quality of life in Croatian children with inflammatory bowel disease
|
Abdovic, Slaven
|
|
2013
|
|
11 |
p. 908-915
8 p.
|
artikel
|
| 54 |
The importance of IGRA in patients candidates for biological therapy
|
Cotter, José
|
|
2013
|
|
11 |
p. 928-929
2 p.
|
artikel
|
| 55 |
The Patient Simple Clinical Colitis Activity Index (P-SCCAI) can detect ulcerative colitis (UC) disease activity in remission: A comparison of the P-SCCAI with clinician-based SCCAI and biological markers
|
Bennebroek Evertsz', Floor
|
|
2013
|
|
11 |
p. 890-900
11 p.
|
artikel
|
| 56 |
The risk of colorectal cancer in patients with inflammatory bowel diseases in Finland: A follow-up of 20years
|
Manninen, Pia
|
|
2013
|
|
11 |
p. e551-e557
nvt p.
|
artikel
|
| 57 |
The risks of post-operative complications following pre-operative infliximab therapy for Crohn's disease in patients undergoing abdominal surgery: A systematic review and meta-analysis
|
Rosenfeld, Greg
|
|
2013
|
|
11 |
p. 868-877
10 p.
|
artikel
|
| 58 |
Treatment of inflammatory bowel disease with methotrexate in clinical practice
|
Magalhães, Ricardo Küttner
|
|
2013
|
|
11 |
p. e606-
1 p.
|
artikel
|
| 59 |
Varicella zoster exposure in IBD patients: Rethink the rash decision
|
Limdi, Jimmy K.
|
|
2014
|
|
11 |
p. 1563-1564
2 p.
|
artikel
|
| 60 |
Viewpoint: Knowledge and viewpoints on biosimilar monoclonal antibodies among members of the European Crohn's and Colitis Organization
|
Danese, Silvio
|
|
2014
|
|
11 |
p. 1548-1550
3 p.
|
artikel
|
Tijdschrift beschrijving